hepatic-detox

Oregon Grape

Mahonia aquifolium (Pursh) Nutt.

The Bitter Bark Corrector

Crystalis is a reference resource for herbal, crystal, and somatic practice.

This library is designed to help readers orient, compare, and research. It is not a substitute for medical care or practitioner judgment.

Botanical / editorial

Family
Berberidaceae
Plant type
Root bark and stem bark (harvested from mature shrubs, dried; the bright yellow inner bark indicates berberine content)
Route
Mixed route
Evidence tier
Mixed evidence
Western North America1000+ Indigenous useBerberidaceae

Botanical / meta

Botanical identity

Pharmacognosy intro

Mahonia aquifolium (Pursh) Nutt. (Berberidaceae), commonly known as Oregon grape, is an evergreen shrub native to the Pacific Northwest of North America. The root bark and stem bark are the primary medicinal parts, containing a rich alkaloid profile dominated by protoberberine isoquinoline alkaloids: berberine (the most pharmacologically significant, 1.5-6% of dried root bark), berbamine, oxyacanthine, jatrorrhizine, columbamine, oxyberberine, and corytuberine. Additionally, the bark contains bisbenzylisoquinoline alkaloids that contribute to the plant's anti-inflammatory profile. The bright yellow color of the inner bark is due entirely to berberine content. Berberine, the primary active alkaloid, operates through a remarkably broad pharmacological mechanism. Its most thoroughly characterized action is activation of AMP-activated protein kinase (AMPK) through phosphorylation of Thr172 on both alpha1 and alpha2 subunits. AMPK activation cascades into enhanced glucose uptake, inhibition of intracellular glucose production, stimulation of glycolysis, and improved lipid and glucose metabolism -- explaining berberine's demonstrated antidiabetic effects comparable to metformin in some clinical trials. At the cellular level, berberine intercalates into DNA, preventing DNA replication and cell proliferation, which underlies its antimicrobial and antiproliferative activity. It inhibits lipoxygenase and lipid peroxidation, reduces T-cell infiltration, suppresses COX-2 activity (reducing prostaglandin E2), and directly inhibits IL-8 production. The crude extract of Mahonia aquifolium stem bark additionally inhibits IL-1, TNF-alpha, and TNF-beta through its bisbenzylisoquinoline alkaloid fraction. In psoriasis, a 10% Mahonia aquifolium bark extract ointment demonstrated efficacy for moderately severe psoriasis vulgaris in clinical study (Wiesenauer & Ludtke, 1996), with the mechanism attributed to antiproliferative effects on keratinocytes and anti-inflammatory modulation of the immune response. Mahonia aquifolium was a cornerstone of Native American medicine in the Pacific Northwest, used by the Coast Salish, Squaxin Island, and Quinault peoples for skin infections, digestive complaints, and as a general tonic. The Eclectics adopted it as a hepatic alterative and antiperiodic (antimalarial). It should be distinguished from the closely related Mahonia nervosa (dull Oregon grape) and Berberis vulgaris (European barberry), all of which share berberine as a principal constituent. Oregon grape root bark is listed in the United States Pharmacopeia National Formulary.

Editorial orientation

The Bitter Bark Corrector

Oregon grape is usually reached for when skin, liver, and digestion are all showing a hotter, more congested edge. It belongs first to the berberine-bitter lane.

Door 1

Body-first read

Hook

Oregon grape should not be written as if bitterness were incidental. Root and stem bark carry the page. This is a plant for congestion with heat in it, not for vague wellness cleansing. Skin irritation, sluggish liver language, and digestive stagnation all make more sense here when the page stays close to its bitter alkaloid character. Oregon grape earns authority by sounding like a correction, not a comfort.

What it is for

Mahonia aquifolium (Pursh) Nutt. (Berberidaceae), commonly known as Oregon grape, is an evergreen shrub native to the Pacific Northwest of North America. The root bark and stem bark are the primary medicinal parts, containing a rich alkaloid profile dominated by protoberberine isoquinoline alkaloids: berberine (the most pharmacologically significant, 1.5-6% of dried root bark), berbamine, oxyacanthine, jatrorrhizine, columbamine, oxyberberine, and corytuberine. Additionally, the bark contains bisbenzylisoquinoline alkaloids that contribute to the plant's anti-inflammatory profile. The bright yellow color of the inner bark is due entirely to berberine content. Berberine, the primary active alkaloid, operates through a remarkably broad pharmacological mechanism. Its most thoroughly characterized action is activation of AMP-activated protein kinase (AMPK) through phosphorylation of Thr172 on both alpha1 and alpha2 subunits. AMPK activation cascades into enhanced glucose uptake, inhibition of intracellular glucose production, stimulation of glycolysis, and improved lipid and glucose metabolism -- explaining berberine's demonstrated antidiabetic effects comparable to metformin in some clinical trials. At the cellular level, berberine intercalates into DNA, preventing DNA replication and cell proliferation, which underlies its antimicrobial and antiproliferative activity. It inhibits lipoxygenase and lipid peroxidation, reduces T-cell infiltration, suppresses COX-2 activity (reducing prostaglandin E2), and directly inhibits IL-8 production. The crude extract of Mahonia aquifolium stem bark additionally inhibits IL-1, TNF-alpha, and TNF-beta through its bisbenzylisoquinoline alkaloid fraction. In psoriasis, a 10% Mahonia aquifolium bark extract ointment demonstrated efficacy for moderately severe psoriasis vulgaris in clinical study (Wiesenauer & Ludtke, 1996), with the mechanism attributed to antiproliferative effects on keratinocytes and anti-inflammatory modulation of the immune response. Mahonia aquifolium was a cornerstone of Native American medicine in the Pacific Northwest, used by the Coast Salish, Squaxin Island, and Quinault peoples for skin infections, digestive complaints, and as a general tonic. The Eclectics adopted it as a hepatic alterative and antiperiodic (antimalarial). It should be distinguished from the closely related Mahonia nervosa (dull Oregon grape) and Berberis vulgaris (European barberry), all of which share berberine as a principal constituent. Oregon grape root bark is listed in the United States Pharmacopeia National Formulary.

Oregon grape is usually reached for when skin, liver, and digestion are all showing a hotter, more congested edge. It belongs first to the berberine-bitter lane.

Route panel

Preparation shapes the claim

Evidence and safety may differ by preparation. Essential oil, tea, tincture, extract, infused oil, and topical use are not interchangeable.

Mixed route

Comparison

What makes this herb distinct

Comparison intro

Oregon grape often gets compared with yellow dock or andrographis, but it sits between them, less acute than andrographis and more heat-marked than yellow dock.

Comparison rule

Choose Oregon grape when bitter correction and skin-liver congestion belong in the same picture. Keep it out of soft household tonic writing.

Quality

Fresh, dried, oil, and garden read

Fresh

Fresh root bark should show strong yellow color within and smell active.

Dried

Dried material should still reveal rich color and bitterness, not pale woody scrap.

Oil lane

Oregon grape is not an oil herb. Root and bark preparations are the honest lane.

Growing tips

It likes woodland edge conditions and should be harvested with conservation awareness.

Companion

Crystal pairing reference

Why this pairing exists

With black tourmaline, Oregon grape reads as decisive bitter clearing with heat reduction.

The polyvagal state addressed by Oregon grape and yellow jasper is the sluggish, dysregulated metabolic state that straddles sympathetic inefficiency and dorsal vagal stagnation. Blood sugar oscillates, energy crashes, the skin breaks out, the liver feels congested. Berberine intervenes at the AMPK switch; flipping on the metabolic cascade that improves insulin sensitivity, enhances lipid metabolism, and reduces inflammatory cytokines. Yellow jasper, placed on the solar plexus during rest or carried in a pocket, serves as a steady-state energetic reminder of metabolic balance. Its dense, opaque quality contrasts with the transparency of clear quartz; it is a stone of substance, not light, appropriate for the heavy metabolic work Oregon grape supports. For practical pairing, take Oregon grape root bark tincture (2 mL) or berberine extract (500 mg) twice daily with meals for a 6-week protocol, holding yellow jasper during morning intention-setting. The bitter taste of the tincture activates the cephalic-phase digestive cascade (TAS2R activation, vagal signaling, gastric acid and bile release) even before the berberine reaches the intestine for systemic absorption. The jasper anchors the morning commitment to metabolic recalibration. After 6 weeks, assess: skin clarity, energy stability, digestive regularity, and blood glucose patterns (if monitored) should all show measurable improvement.

Crystal side

Companion crystal

Door 2

Compound and clinical layer

Clinical and compound notes are included as a research layer, not as treatment instructions.

Safety intro

Contraindications: Contraindicated in pregnancy (berberine has demonstrated uterine stimulant activity and may induce preterm labor; berberine also displaces bilirubin from albumin, posing theoretical risk of kernicterus in neonates). Contraindicated during lactation. Not recommended for children under 2 years. Use with caution in individuals with hypotension (berberine lowers blood pressure). Drug Interactions: Berberine inhibits CYP2D6, CYP2C9, and CYP3A4. Clinically significant interactions documented with cyclosporine (increased cyclosporine levels by 29% in renal transplant patients). May potentiate oral hypoglycemic agents and insulin (additive glucose-lowering effect). May potentiate antihypertensive medications. Berberine increases the bioavailability of metformin. May interact with anticoagulants through CYP2C9 inhibition. Pregnancy/Lactation: Contraindicated. Category X equivalent. Berberine crosses the placenta and has demonstrated uterine stimulant effects. Displaces bilirubin from albumin binding sites, creating theoretical risk of neonatal jaundice/kernicterus. Hepatotoxicity Risk: Rare reports of hepatotoxicity with berberine-containing preparations at high doses. Monitor liver function with prolonged use of concentrated extracts. Dosage Ranges: Dried root bark decoction: 1-3 g in 250 mL water, simmered 15 minutes, three times daily. Tincture (1:5, 60% ethanol): 1-3 mL three times daily. Standardized berberine extract: 500-1500 mg berberine daily in divided doses (primarily from Berberis or Coptis sources). Topical: 10% bark extract ointment for psoriasis. Adverse Reactions: GI disturbance (nausea, diarrhea, constipation) in approximately 10-15% of users at higher doses. Bitter taste may provoke nausea. Yellow staining of skin and mucous membranes at high doses.

Resource framing

Crystalis is a reference resource for herbal, crystal, and somatic practice.

This library is designed to help readers orient, compare, and research. It is not a substitute for medical care or practitioner judgment.

Clinical and compound notes are included as a research layer, not as treatment instructions.

Evidence and safety may differ by preparation. Essential oil, tea, tincture, extract, infused oil, and topical use are not interchangeable.